-transparent.png){kind=logo}
In view of their potentially dangerous proarrhythmic effects, antiarrhythmic drugs should only be prescribed for patients with poorly tolerated symptomatic supraventricular arrhythmias. The choice of a suitable preparation depends not only on the type of arrhythmia, but also on the underlying heart disease and left-ventricular function. Digoxin, verapamil, sotalol and quinidine remain first-line drugs, while in view of recent trials the type-1c antiarrhythmics (flecainide) should only be given in cases resistant to other agents. Amiodarone is also an important and efficacious "reserve" antiarrhythmic, which has to be utilized at low doses to avoid its well-known side effects.
F Follath, and
R Candinas, and
B Meyer
August 1991,
Cardiologia (Rome, Italy),
F Follath, and
R Candinas, and
B Meyer
October 2022,
Heart (British Cardiac Society),
F Follath, and
R Candinas, and
B Meyer
January 1998,
Clinical oncology (Royal College of Radiologists (Great Britain)),
F Follath, and
R Candinas, and
B Meyer
January 1980,
[Kango gijutsu] : [Nursing technique],
F Follath, and
R Candinas, and
B Meyer
April 1971,
JAMA,
F Follath, and
R Candinas, and
B Meyer
December 2016,
Medwave,
F Follath, and
R Candinas, and
B Meyer
October 1971,
Die Medizinische Welt,
F Follath, and
R Candinas, and
B Meyer
July 1973,
Die Medizinische Welt,
F Follath, and
R Candinas, and
B Meyer
September 1993,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
F Follath, and
R Candinas, and
B Meyer
June 1984,
British journal of anaesthesia,
